Get the Stockscreener App
2.74
8.67%
-0.26
After Hours:
2.67
-0.07
-2.55%
Psyence Biomedical Ltd stock is traded at $2.74, with a volume of 167.96K.
It is down -8.67% in the last 24 hours and down -14.91% over the past month.
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
See More
Previous Close:
$3.00
Open:
$2.94
24h Volume:
167.96K
Relative Volume:
0.12
Market Cap:
$5.12M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-17.47%
1M Performance:
-14.91%
6M Performance:
-20.79%
1Y Performance:
-93.22%
1-Day Range:
$2.50
$2.94
1-Week Range:
$2.50
$3.3199
52-Week Range:
$2.36
$63.36
Psyence Biomedical Ltd Stock (PBM) Company Profile
Compare PBM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
2.74 | 702.84K | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Psyence Biomedical Ltd Stock (PBM) Latest News
How to build a custom watchlist for Psyence Biomedical Ltd. Equity WarrantJuly 2025 Closing Moves & Safe Entry Zone Tips - newser.com
How sentiment analysis helps forecast Psyence Biomedical Ltd. Equity WarrantBuy Signal & Fast Gain Swing Alerts - newser.com
What momentum indicators show for Psyence Biomedical Ltd. stockJuly 2025 Volume & Technical Entry and Exit Tips - newser.com
What machine learning models say about Psyence Biomedical Ltd. Equity WarrantPortfolio Update Summary & Smart Investment Allocation Insights - newser.com
How analysts rate Psyence Biomedical Ltd. stock todayJuly 2025 Big Picture & Risk Controlled Daily Plans - newser.com
Psyence Biomedical invests $3.5 million in psychedelic API producer By Investing.com - Investing.com Nigeria
Can Psyence Biomedical Ltd. Equity Warrant recover in the next quarter2025 Winners & Losers & Free Community Supported Trade Ideas - newser.com
Will Psyence Biomedical Ltd. Equity Warrant stock go up soonJuly 2025 Selloffs & Low Volatility Stock Recommendations - newser.com
What momentum indicators show for Psyence Biomedical Ltd. Equity Warrant stock2025 Market Outlook & Growth Focused Investment Plans - newser.com
Psyence BioMed Strengthens Strategic Partnership with PsyLabs Through USD $3,500,000 Follow-On Investment - The Manila Times
How Psyence Biomedical Ltd. Equity Warrant stock performs during Fed tightening cyclesJuly 2025 News Drivers & High Conviction Buy Zone Picks - newser.com
Published on: 2025-11-03 05:47:02 - newser.com
Using data tools to time your Psyence Biomedical Ltd. exitWeekly Market Summary & Reliable Breakout Stock Forecasts - newser.com
Will Psyence Biomedical Ltd. Equity Warrant stock pay special dividendsLong Setup & Consistent Growth Stock Picks - newser.com
Understanding Psyence Biomedical Ltd.’s price movement2025 Biggest Moves & Precise Entry and Exit Recommendations - newser.com
Applying Elliott Wave Theory to Psyence Biomedical Ltd.CPI Data & Fast Moving Trade Plans - newser.com
Why retail investors favor Psyence Biomedical Ltd. Equity Warrant stockEarnings Risk Summary & Free High Return Stock Watch Alerts - newser.com
Will Psyence Biomedical Ltd. see short term momentumJuly 2025 Gainers & Free Safe Entry Trade Signal Reports - newser.com
Analyzing recovery setups for Psyence Biomedical Ltd. investorsInsider Buying & Free Technical Pattern Based Buy Signals - newser.com
Why Psyence Biomedical Ltd. Equity Warrant stock is a value investor pickMarket Activity Report & Long-Term Safe Investment Plans - newser.com
Visual analytics tools that track Psyence Biomedical Ltd. Equity Warrant performanceRate Cut & Reliable Intraday Trade Alerts - newser.com
Real time breakdown of Psyence Biomedical Ltd. Equity Warrant stock performanceJuly 2025 Decliners & Fast Gaining Stock Strategy Reports - newser.com
What to do if you’re stuck in Psyence Biomedical Ltd.Earnings Recap Report & Capital Efficient Trade Techniques - newser.com
Is Psyence Biomedical Ltd. Equity Warrant stock trading at a premium valuationTrade Exit Summary & Free Safe Entry Trade Signal Reports - newser.com
Strategies to average down on Psyence Biomedical Ltd. Equity WarrantMarket Growth Report & Low Drawdown Momentum Trade Ideas - newser.com
Is Psyence Biomedical Ltd. trending in predictive chart modelsMarket Activity Recap & Precise Swing Trade Entry Alerts - newser.com
Applying chart zones and confluence areas to Psyence Biomedical Ltd. Equity WarrantWeekly Investment Report & Technical Confirmation Alerts - newser.com
How Psyence Biomedical Ltd. Equity Warrant stock performs in stagflationQuarterly Risk Review & Weekly Stock Breakout Alerts - newser.com
Will Psyence Biomedical Ltd. stock remain a Wall Street favoriteTrade Risk Report & Detailed Earnings Play Alerts - newser.com
How to monitor Psyence Biomedical Ltd. with trend dashboardsStop Loss & AI Driven Price Forecasts - newser.com
How to build a dashboard for Psyence Biomedical Ltd. stockJuly 2025 Reactions & Free Reliable Trade Execution Plans - newser.com
Is Psyence Biomedical Ltd. stock attractive after correctionTrade Ideas & Expert Curated Trade Ideas - newser.com
Psyence Biomedical Ltd Stock (PBM) Financials Data
There is no financial data for Psyence Biomedical Ltd (PBM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.45%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):